Dr. Reddy’s Lab. Launched Fulvestrant Injection

Hyderabad, Sept.7 (Maxim News): Dr. Reddy’s Laboratories Ltd. today announced the launch of Fulvestrant Injection, 250 mg/5 mL (50 mg/mL) per Single-dose Syringe, a therapeutic equivalent generic version of Faslodex (fulvestrant) Injection, 250 mg/5 mL (50 mg/mL), approved by the U.S. Food and Drug Administration (USFDA).

The Faslodex brand and generic market had U.S. sales of approximately $­­­­­407 million MAT for the most recent twelve months ending in June 2020 according to IQVIA Health.

Dr. Reddy’s Fulvestrant Injection, 250 mg/5 mL (50 mg/mL) per Single-dose Syringe is available in a carton containing two 5 mL single-dose prefilled syringes. (Maxim News)

Now you can get latest stories from Indtoday on Telegram everyday. Click the link to subscribe.  Click to follow Indtoday Facebook page and Twitter and on Instagram

Leave A Reply

Your email address will not be published.